Daewon Pharmaceutical Co., Ltd. (KRX:003220)
10,300
+70 (0.68%)
At close: Apr 10, 2026
-17.86% (1Y)
| Market Cap | 219.26B -27.4% |
| Revenue (ttm) | 605.43B +1.2% |
| Net Income | -1.38B |
| EPS | -87.38 |
| Shares Out | 21.43M |
| PE Ratio | n/a |
| Forward PE | 28.82 |
| Dividend | 300.00 (2.93%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 40,960 |
| Average Volume | 26,133 |
| Open | 10,230 |
| Previous Close | 10,230 |
| Day's Range | 10,090 - 10,310 |
| 52-Week Range | 9,670 - 14,700 |
| Beta | 0.26 |
| RSI | 43.23 |
| Earnings Date | May 15, 2026 |